Growth-inhibitory properties of vasoactive intestinal polypeptide
- 1 August 1988
- journal article
- research article
- Published by Elsevier BV in Regulatory Peptides
- Vol. 22 (3), 267-274
- https://doi.org/10.1016/0167-0115(88)90039-0
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Synthesis and release of Vasoactive Intestinal Polypeptide (VIP) by mouse neuroblastoma cells: Modulation by cyclic nucleotides and ascorbic acidPeptides, 1985
- Adenosine receptor‐mediated changes in cyclic AMP production and DNA synthesis in cultured arterial smooth muscle cellsJournal of Cellular Physiology, 1985
- Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancerNature, 1985
- Stimulation of connective tissue cell growth by substance P and substance KNature, 1985
- Autocrine growth factors and cancerNature, 1985
- Gastrin releasing peptide is a selective mitogen for small cell lung carcinoma in vitro.JCI Insight, 1985
- Bombesin and the C-terminal tetradecapeptide of gastrin-releasing peptide are growth factors for normal human bronchial epithelial cellsExperimental Cell Research, 1984
- Forskolin, cyclic AMP and cellular physiologyTrends in Pharmacological Sciences, 1983
- Role of Cyclic Nucleotides in Growth ControlAnnual Review of Biochemistry, 1975
- Cyclic GMP and cyclic AMP levels in normal and transformed fibroblastsNature, 1974